Literature DB >> 18602805

A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly.

T Maruyama1, M S Niederman, T Kobayashi, H Kobayashi, T Takagi, C N D'Alessandro-Gabazza, H Fujimoto, P Gil Bernabe, S Hirohata, S Nakayama, K Nishikubo, H Yuda, A Yamaguchi, E C Gabazza, T Noguchi, Y Takei, O Taguchi.   

Abstract

There are no prospective comparison of the etiology and clinical outcome between hospital-acquired pneumonia (HAP) and nursing home-acquired pneumonia (NHAP) in non-intubated elderly. This study prospectively evaluated the etiology of HAP and NHAP in non-intubated elderly. A prospective cohort study was carried out in a rural region of Japan where the population over 65 years of age represents 30% of the population. A total of 108 patients were enrolled. There were 33 patients with HAP and 75 with NHAP. Etiologic diagnosis was established in 78.8% of HAP and in 72% of NHAP patients. The most frequent pathogens were Chlamydophila pneumoniae followed by Streptococcus pneumoniae, Staphylococcus aureus and Influenza virus. The frequency of Streptococcus pneumoniae and Influenza virus was significantly higher, whereas the frequency of Staphylococcus aureus and Enterobacteriaceae was significantly lower in NHAP compared to HAP. Performance and nutritional status were significantly worse in patients with HAP than in those with NHAP. Hospital mortality was significantly lower in patients with NHAP compared to those with HAP. This study demonstrated that C. pneumoniae, Streptococcus pneumoniae, Staphylococcus aureus and Influenza virus are frequent causative agents of pneumonia in non-intubated elderly and that the responsible pathogens and clinical outcome differ between NHAP and HAP.

Entities:  

Mesh:

Year:  2008        PMID: 18602805     DOI: 10.1016/j.rmed.2008.03.027

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  12 in total

1.  Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients.

Authors:  A Putot; J Tetu; S Perrin; H Bailly; L Piroth; J-F Besancenot; B Bonnotte; P Chavanet; P d'Athis; P-E Charles; H Sordet-Guépet; P Manckoundia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-11       Impact factor: 3.267

2.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Authors:  Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

3.  Role of Atypical Bacteria in Hospitalized Patients With Nursing Home-Acquired Pneumonia.

Authors:  Laura Meyer-Junco
Journal:  Hosp Pharm       Date:  2016-10

4.  Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial.

Authors:  Takaya Maruyama; Osamu Taguchi; Michael S Niederman; John Morser; Hiroyasu Kobayashi; Tetsu Kobayashi; Corina D'Alessandro-Gabazza; Sei Nakayama; Kimiaki Nishikubo; Takashi Noguchi; Yoshiyuki Takei; Esteban C Gabazza
Journal:  BMJ       Date:  2010-03-08

5.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

6.  Interrupted time-series analyses of routine vaccination program for elderly pneumonia patients in Japan; an ecological study using aggregated nationwide inpatient data.

Authors:  Koichi Kobayashi; Taisuke Jo; Wataru Mimura; Maho Suzukawa; Nobuharu Ohshima; Goh Tanaka; Manabu Akazawa; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga; Takahide Nagase; Hideaki Nagai
Journal:  Hum Vaccin Immunother       Date:  2021-04-20       Impact factor: 3.452

7.  The difference in clinical presentations between healthcare-associated and community-acquired pneumonia in university-affiliated hospital in Korea.

Authors:  Eun Ju Jeon; Sung-Gun Cho; Jong Wook Shin; Jae Yeol Kim; In Won Park; Byoung Whui Choi; Jae Chol Choi
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

8.  Persistence and complex evolution of fluoroquinolone-resistant Streptococcus pneumoniae clone.

Authors:  Debby Ben-David; Mitchell J Schwaber; Amos Adler; Samira Masarwa; Rotem Edgar; Shiri Navon-Venezia; David Schwartz; Nurith Porat; Tali Kotlovsky; Nikolay Polivkin; Irina Weinberg; Avraham Lazary; Nissim Ohana; Ron Dagan
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

Review 9.  Nursing Home-Associated Pneumonia, Part II: Etiology and Treatment.

Authors:  Joseph M Mylotte
Journal:  J Am Med Dir Assoc       Date:  2020-02-13       Impact factor: 4.669

10.  Hospital utilization rates for influenza and RSV: a novel approach and critical assessment.

Authors:  Emily K Johnson; Dillon Sylte; Sandra S Chaves; You Li; Cedric Mahe; Harish Nair; John Paget; Tayma van Pomeren; Ting Shi; Cecile Viboud; Spencer L James
Journal:  Popul Health Metr       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.